Phase 2 study of intermittent pulse dacomitinib in patients with advanced non-small cell lung cancers. [electronic resource]
Producer: 20180705Description: 195-199 p. digitalISSN:- 1872-8332
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Protein Kinase Inhibitors -- administration & dosage
- Pulse Therapy, Drug
- Quinazolinones -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.